-transparent.png){kind=logo}
Adenosine deaminase (ADA) activity has been assessed in lymphoid cells of 23 patients with acute lymphoblastic leukaemia (ALL) in order to attempt a further characterization of ALL cells in addition to the well known cytochemical and immunological T and B lymphoid cell markers. ADA activity did not show any correlation with the immunological characterization of the patients investigated; in fact a wide range of ADA activity was observed with levels ranging from 0 to 32 U in T-ALL patients and nearly similar values (from 1.8 to 36 U) in the group of non T--non B ALL cases. Normal values ranged from 2 to 5 U (mean 2.9 U; s.d. +/- 0.8). Some cytochemical patterns (acid phosphatase and PAS) appeared well correlated with T markers of lymphoid cells, whereas they showed no significant relationship with ADA activity.
V Liso, and
A Tursi, and
G Specchia, and
G Troccoli, and
M P Loria, and
L Bonomo
January 1989,
Folia haematologica (Leipzig, Germany : 1928),
V Liso, and
A Tursi, and
G Specchia, and
G Troccoli, and
M P Loria, and
L Bonomo
April 1982,
Haematologica,
V Liso, and
A Tursi, and
G Specchia, and
G Troccoli, and
M P Loria, and
L Bonomo
May 1975,
British journal of cancer,
V Liso, and
A Tursi, and
G Specchia, and
G Troccoli, and
M P Loria, and
L Bonomo
July 2005,
Clinical and experimental medicine,
V Liso, and
A Tursi, and
G Specchia, and
G Troccoli, and
M P Loria, and
L Bonomo
November 1984,
British journal of haematology,
V Liso, and
A Tursi, and
G Specchia, and
G Troccoli, and
M P Loria, and
L Bonomo
January 1982,
Clinical and laboratory haematology,
V Liso, and
A Tursi, and
G Specchia, and
G Troccoli, and
M P Loria, and
L Bonomo
April 1983,
Scandinavian journal of haematology,
V Liso, and
A Tursi, and
G Specchia, and
G Troccoli, and
M P Loria, and
L Bonomo
June 1993,
Annals of hematology,
V Liso, and
A Tursi, and
G Specchia, and
G Troccoli, and
M P Loria, and
L Bonomo
January 1977,
Klinische Padiatrie,
V Liso, and
A Tursi, and
G Specchia, and
G Troccoli, and
M P Loria, and
L Bonomo
July 1980,
Lancet (London, England),
